|1.||Lane, Hsien-Yuan: 8 articles (09/2014 - 03/2004)|
|2.||Strzelecki, Dominik: 6 articles (12/2015 - 01/2014)|
|3.||Tsai, Guochuan E: 6 articles (02/2012 - 11/2005)|
|4.||Kałużyńska, Olga: 5 articles (12/2015 - 01/2015)|
|5.||Zitka, Ondrej: 5 articles (01/2015 - 01/2013)|
|6.||Kizek, Rene: 5 articles (01/2015 - 01/2013)|
|7.||Adam, Vojtech: 5 articles (01/2015 - 01/2013)|
|8.||Chang, Yue-Cune: 5 articles (05/2010 - 11/2005)|
|9.||Kotlicka-Antczak, Magdalena: 4 articles (10/2015 - 01/2015)|
|10.||Koo, Ja Seung: 4 articles (05/2015 - 01/2014)|
|1.||Schizophrenia (Dementia Praecox)
12/15/2015 - "This is the first randomized placebo-controlled study to examine the metabolic safety of sarcosine in patients with schizophrenia. "
12/15/2015 - "This study was undertaken with the purpose to determine if there are changes in metabolic parameters during 6-month add-on treatment with sarcosine in patients with schizophrenia. "
10/08/2015 - "This is the first study showing that a pharmacological intervention in schizophrenia, particularly augmentation of the antypsychotic treatment with sarcosine, may reverse the pathological increase in glutamatergic transmission in the hippocampus. "
10/08/2015 - "The aim of the study was to assess the effects of sarcosine on metabolism parameters in the left hippocampus in patients with schizophrenia. "
01/01/2015 - "Safety, tolerability and pharmacokinetics of open label sarcosine added on to anti-psychotic treatment in schizophrenia - preliminary study."
01/01/2015 - "Herein, we describe an ultrasensitive specific biosensing system for detection of sarcosine as a potential biomarker of prostate carcinoma based on Förster resonance energy transfer (FRET). "
11/01/1986 - "When the mice were intubated with a single dose of nitroso-sarcosine-ethylester (NSEE), the incidence of the forestomach carcinoma was only 9.5%. "
12/01/1991 - "In vivo, green tea extract decreased the incidence of carcinoma in the forestomach and esophagus of mice induced by sarcosine and NaNO2. "
04/01/2014 - "In this study, we monitored the abundance of potential non-invasive markers of prostate carcinoma such as amino acid sarcosine, involved in the metabolism of amino acids and methylation processes, ongoing during the progression of prostate carcinoma. "
08/01/2009 - "Uptake by Caco-2 cells (human carcinoma cell line) and HeLa cells transfected with peptide transporter 1 (HeLa/PEPT1) was time- and temperature-dependent and was inhibited by typical PEPT1 inhibitors such as glycyl-sarcosine (Gly-Sar). "
03/01/2010 - "Conversely, sarcosine showed weak anticonvulsant properties by increasing the threshold current for the induction of tonic seizures. "
03/01/2010 - "The present findings indicate that sarcosine did not lower the seizure threshold. "
03/01/2010 - "In the iv PTZ test, sarcosine did not exert a significant effect on the seizure threshold at any of the doses tested (100, 200, 400 and 800 mg/kg, ip). "
02/01/2008 - "Furthermore, pretreatment with sarcosine was effective in controlling pentylenetetrazol-induced seizures. "
03/01/2010 - "Therefore, we examined the effects of sarcosine on the seizure threshold in two different mouse seizure models: the timed intravenous (iv) pentylenetetrazole (PTZ) infusion test and the maximal electroshock seizure threshold test. "
01/01/2014 - "After obtaining an informed consent, we started administration of 2 g of sarcosine per day to treat persistent negative and cognitive symptoms. "
02/01/2008 - "Full agonists of the glycine site, glycine and D-serine and a glycine transporter-1 inhibitor, sarcosine, added to antipsychotic drugs, have been shown to be effective in the treatment of negative symptoms and possibly cognitive symptoms without significantly affecting the positive symptoms of schizophrenia. "
01/01/2015 - "In this article, we describe a case of a 34-year-old woman with diagnosis of schizophrenia with persistent moderate negative and cognitive symptoms, a participant of the Polish Sarcosine Study (PULSAR) treated with olanzapine (25 mg per day) and venlafaxine (75 mg per day). "
02/01/2015 - "We found that PCA3, phi and sarcosine levels were significantly higher in patients with tumor volume (TV)≥0.5 ml, pathologic Gleason sum (GS)≥7 and pT3 disease (all p-values≤0.01). "
01/01/2015 - "Among cancer cases, nominal logistic regression was used for the association of sarcosine with Gleason grade. "
01/01/2015 - "For cancer cases, pre-diagnostic serum was utilized for sarcosine measurement. "
11/01/2012 - "We provide evidence that serum sarcosine has a higher predictive value than tPSA and %fPSA in patients with PSA < 4 ng/ml. Moreover, sarcosine levels were significantly different in low grade versus high grade cancers in this subset of patients, suggesting that this marker may be a further tool not only for diagnosing PCa in normal PSA and abnormal DRE/TRUS patients but also for selecting candidates for non-aggressive therapies and active surveillance."
11/01/2012 - "Moreover, in patients with a PSA < 4 ng/ml, the percentage of low/intermediate-grade cancers was positively associated with sarcosine levels (P = 0.005). "
|1.||Glycine (Aminoacetic Acid)
|6.||Antipsychotic Agents (Antipsychotics)
|7.||Risperidone (Risperdal Consta)
|9.||Uric Acid (Urate)
|10.||Teniposide (VM 26)
|2.||Prostatectomy (Retropubic Prostatectomy)
|5.||Highly Active Antiretroviral Therapy (HAART)